Share on LinkedInShare on LinkedIn

ARTICLE · 18 JANUARY 2023

CCI Dismisses Allegations Against Sanofi India Limited

AZB & Partners
AZB & Partners
Contributor
AZB & Partners

AZB & Partners

AZB & Partners, one of India’s premier law firms was founded in 2004 with a clear purpose to...

View firm profile
Explore more from AZB & Partners

On October 14, 2022, the CCI dismissed a complaint filed by one Mr. Pinesh S. Doriwala (‘Informant') against Sanofi India Limited (‘Sanofi') alleging anti-competitive conduct...

IndiaAntitrust/Competition Law

On October 14, 2022, the CCI dismissed a complaint filed by one Mr. Pinesh S. Doriwala (‘Informant') against Sanofi India Limited (‘Sanofi') alleging anti-competitive conduct in contravention of Section 3(4)(d) of the Competition Act.1

The Informant is a partner in Shri Shriman Narayan Rahat Dava Centre (‘SSNRDC'), a firm that deals in pharmaceutical products at a special discount rate of 20%-35% of the Maximum Retail Price (‘MRP') for Indian Army, senior citizens, disabled individuals and NRIs and others. SSNRDC delivers pharmaceutical products at doorsteps without any advance payment.

Sanofi is primarily engaged in the business of manufacturing and trading of pharmaceutical products of leading brands in therapeutic uses for diabetes, cardiology, thrombosis, antihistamines, and central nervous system to the consumers in India.

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from